Llwytho...
Therapeutic strategies with oral fluoropyrimidine anticancer agent, S-1 against oral cancer()
Oral cancer has been recognized as a tumor with low sensitivity to anticancer agents. However, introduction of S-1, an oral cancer agent is improving treatment outcome for patients with oral cancer. In addition, S-1, as a main drug for oral cancer treatment in Japan can be easily available for outpa...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Jpn Dent Sci Rev |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Elsevier
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5501734/ https://ncbi.nlm.nih.gov/pubmed/28725297 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jdsr.2016.11.001 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|